Yeggles retweeted
šAnson Funds have just ratted out CIBC to the DOJ on their stock lending fraud
marketfrauds.to/anson-funds-ā¦
#anson #funds #moez #kassam @kshaughnessy2 @stephmase22 #CIBC @DOJCrimDiv @SECGov @MarioNawfal @BBCBreaking @business
Yeggles retweeted
>Pay $60 for digital game
>Itās just a license
>Canāt share the game or sell it
>Servers shut down and left with nothing
Remind me again how this is the future?
Yeggles retweeted
Brett Harrison, former head of FTX US, has made a long thread regarding FTX US and his time there.
In December, Unusual Whales spoke to SBF where he said tokenized shares of $AMC, $GME were backed 1:1.
Here is a video of Brett saying the same from Sept from a AMA with Reddit.
Readers added context they thought people might want to know
This post has continuously been altering its Likes, When there is proof out there that itās higher than whatās been shown, Likes are being removed to bury the post. Itās an important video that shows proof of a rigged stock market.
x.com/jordan_a_m_c/sā¦
Yeggles retweeted
šØFYI SOFTBANK IS BORROWING AGAINST ITS SHARES LIKE #FTX WAS DOING USING $FTT šØ
~3bn $USD loan out there
Furthermore Masa Son already pledged 35% of his shares as collateral (like @SBF_FTX was doing with $FTT)
Who are the crazy brokers onboard with this? š¤¦š»āāļø
@ParrotCapital
#JustDarioDaily
šØIN A SCRAMBLE TO SURVIVE, SOFTBANK IS KILLING ALIBABA! šØ
$BABA closed the last session crashing 9% after results beating expectations across the board, leaving many dumbfounded. Of course, the media quickly made up a narrative to write a story that could more or less fit the price action: "Alibaba crashes after pulling its Cloud Unit listing due to US sanctions risk." I won't waste characters explaining why this is an asinine excuse.
A few days ago, I wrote a short post titled "SOFTBANK SOLD BABA TO THE DEVIL TO GET CASH AND TRY TO SAVE ITSELF" (xitter.cf/dariocpx/status/172252ā¦). However, I realized that many didn't understand what I meant. Today, after $BABA's crash, it's time for me to explain. šš»
On August 10, 2022, Softbank announced the physical settlement of PREPAID FORWARD CONTRACTS (pic1) related to its $BABA shares. At that time, Softbank owned 23.7% of $BABA. When all these derivative contracts expire, they will be left with only 3.8% of $BABA shares.
What is a "Prepaid forward contract"? In this derivative, the buyer of shares (brokers in this case) pays IN ADVANCE to the seller (Softbank) the present value of the future sale price agreed upon. At that time, $BABA shares were trading at $100. So, thanks to this "trade," Softbank immediately booked a gain for the quarter since they were marking-to-market their $BABA holdings at ~$91 at that time. Furthermore, banks paid them a (badly needed) $11 billion in Cash (can you imagine that at that time $JPY was trading at 135 against $USD? š).
The overall gain for Softbank out of this whole masterpiece of financial engineering was ~$34 billion at that time. šš»
ā ļø Important ā ļø
There is a small problem in this scheme. If the price of $BABA were to go up above the forward sale price, Softbank would be on the hook with its brokers to post more collateral and/or return some of the cash they got in advance. š
At that time, Softbank didn't close a single contract, but they agreed on multiple with many brokers on different maturities. By design, the longer the tenor of the forward contract, the bigger the discount applied to brokers and the lower the $BABA price above which Softbank would be on the hook.
Imagine for a second if the #stocks #FOMO would have bit $BABA like it happened to the #Mag7. That would have been a disaster for Softbank, right? Imagine if instead of trading at a 19 PE, $BABA would trade at a 117 PE like $NVDA does. Despite the economic struggles of China, Alibaba revenue growth still held up (chart1). So how come there is such a massive gap from US peers? Because no one, starting from Softbank, has an interest in squeezing this fallen angelš. The chart of $BABA since the start of these forward contracts is pretty self-explanatory (chart2).
The obvious benefit for Softbank of Alibaba's price going down is even written black on white in their financial reports! (Latest one in pic4).
By the way, if you think Jack Ma is throwing in the towel and deciding to sell ~$850 million of his shares at these depressed prices, then you might want to have a look at how much margin lending $BABA founder and early investors got against their #Stocks. Jack Ma just got margin called, period. š¤·š»āāļø
Yeggles retweeted
I've decided to keep everyone looped in in real time since this weekend the global @AMCTheatres supporters helped @CEOAdam and myself link up via X. I sent the email after a weekend of touring and am awaiting a reply. This is potentially massive moment for standup as well as for AMC so I can't wait to share any more intel once we connect. Thx for al the exuberant positive responses over the weekend all. Happy Monday!
Yeggles retweeted
I donāt think @CEOAdam reads his X feed but if he wants to distribute the biggest comedy special of 2024 he should find me here. The final edit is overscaled 4k bc I shot if for the big screen. If not maybe @elonmusk wants to do the first direct premiere on X on New Years Eve? I canāt wait to share this. #comedyislife
Replying to @DaneCook @AMCTheatres
Have your people reach out to AMC Independent if they haven't.
Maybe @CEOAdam could help you with the process.
xitter.cf/Xx_WiReD_xX/status/161ā¦
Yeggles retweeted
šØ LAST DAY šØ
One more day to stream #APESTOGETHERSTRONG in its entirety on X āĀ @elonmusk, a whole documentary on X? Check it out! š
xitter.cf/i/broadcasts/1OyJAWPNMā¦
Share it far and wide yāall!
#ApesTogetherStrong #Apes #GME #AMC #DumbMoney
Yeggles retweeted
Watch #APESTOGETHERSTRONG | FULL DOCUMENTARY | LIVE ON š
Movie starts at 3PM! SHARE THIS LINK for all to see the truth behind #DUMBMONEY
šØFree for all/pay what you want
Support the filmmakers and pay what you can below; every bit helps! xitter.cf/i/broadcasts/1OyJAWPNMā¦
Yeggles retweeted
WATCH THE FULL FILM #ApesTogetherStrong
š¦LIVE ON TWITTER š¦§
šļøOct 7 | 3pm PST
šØFree for all/pay what you want šØ
SHARE/RT/POSTš¦šš¦§
š„š„Letās show the normal folks out there what youāve been fighting for š„š„
Learn the truth behind #DumbMoney
š„šøFind out how rigged #WallSt really isšøš„
Watch #ApesTogetherStrong on @PrimeVideo
amazon.com/gp/video/detail/Bā¦
Yeggles retweeted
Rewatching The Game Changers on @netflix, with a through new frame of 'watching 3 years of market corruption, manipulation, and malpractice', and UFC Fighter James Wilks (@lightningwilks) said something that resonated with me:
āWith overwhelming scientific evidence connecting animal foods to many of the most common deadly diseases, I discovered that the meat, diary, and eggs industries have engaged in a covert response; funding studies that deny this evidence while burying their involvement in the fine print.
One of the hired guns paid to conduct these studies is Exponent, Inc. A company whose research was used by the tobacco industry to deny the connection between second-hand smoke and cancer.
For more than 50 years, Exponent has generated studies that challenged the health risks of everything from asbestos, arsenic, and mercury, to animal foods.ā
---
I thought to myself, "Hey. This sounds a lot like what big money does with 'main stream media' with a short and distort in the stock market and capital markets"
Naturally, I started digging.
<devioussmirk.gif>
---
So, who is Eįµ”ponent, anyway?
According to their website,
"In an era of radically-accelerating change, Eįµ”ponent is the only premium engineering and scientific consulting firm with the depth and breadth of expertise to solve your most profoundly unique, unprecedented, and urgent challenges".
---
What do they do?
Again, according to their website, Eįµ”ponent's corporate mission is:
"To create an unrivaled environment of engineering and scientific expertise, collaboration, and opportunity for exceptional people to produce breakthrough insights and objective solutions for our clients' vital challenges".
Eįµ”ponent also states that their vision is to:
"...solve the most formidable scientific and engineering challenges to create a safer, healthier, sustainable world."
---
To paraphrase...
Eįµ”ponent creates [scientific] expertise that creates opportunities for their clients by solving [scientific] challenges for a safer and healthier world.
.....sounds to me like "we help our clients find creative ways to make money using science". But let's see if there's anything to support that.
---
Let's look at some of Eįµ”ponent (EXPO) owners...
1. BlackRock owns 6,014,847 shares of EXPO
2. Vanguard owns 5,007,031 shares, along with an additional 2,888,199 shares of EXPO through two funds
3. State Street owns 1,690,776 shares of EXPO
..along with some others I am unfamiliar with. Let's dive in, shall we?
4. Kayne Anderson Rudnick Investments owns 4,277,177 shares of EXPO.
Upon further investigation, we see that Kayne Anderson Rudnick--a Los Angeles investment firm--is owned by Kayne Anderson Rudnick and Virtus Investment, according to 13G filings from HeadHunter Group PLC.
You'll never guess who the two largest owners of Virtus Investment are?!?!
⢠BlackRock, who owns 14%, or 13.99% to be specific of Virtus Investment, and
⢠Vanguard, who owns 12.35% of Virtus Investment
...you get the point!
---
Who are BlackRock and Vanguard, and why does this matter?
An 2022 Reuters article titled 'Fact Check-Video claiming BlackRock and Vanguard āown all the biggest corporations in the worldā is missing context' states:
"While it is true that both investment firms hold significant shares in many of the worldās leading companies and can therefore wield voting rights, shares are ultimately owned by Blackrock and Vanguardās clients"
-
Real quick on voting rights...
Investopedia informs us that voting rights afford shareholders the ability to use their votes to influence "...matters of corporate policy, including decisions on the makeup of the board of directors, issuing new securities, initiating corporate actions like mergers or acquisitions, approving dividends, and making substantial changes in the corporation's operations".
-
The fact that Reuters was compelled enough--likely by BlackRock and Vanguard--to publish that article, says enough for me. But let's press on.
-
According to Google, BlackRock has $8.59 trillion in assets under management, while Vanguard has $7.2 trillion in assets under management.
I bet that kind of buying brings with it a lot of influence.
-
A 2020 CNN Business article discussing the 3 largest asset managers--BlackRock, Vanguard, and State Street--stated:
"The rapid growth of the Big Three fund managers, driven in part by rise of dirt-cheap ETFs, gives them enormous sway over financial markets and the priorities of Corporate America"
---
In the case of BlackRock,
"The asset manager also employs both a former Federal Reserve vice chairman and a former head of the Swiss National Bank.
BlackRock is so powerful that the federal government has asked for its help during each of the past two recessions. In March, the Fed tapped BlackRock to manage a first-of-its kind vehicle to buy corporate debt, including junk bonds".
---
Looking back further, we see a 2017 Financial Post article titled With $20 trillion between them, Blackrock and Vanguard could own almost everything by 2028 that begins with:
"Imagine a world in which two asset managers call the shots, in which their wealth exceeds current U.S. GDP and where almost every hedge fund, government and retiree is a customer.
Itās closer than you think. BlackRock Inc. and Vanguard Group ā already the worldās largest money managers ā are less than a decade from managing a total of US$20 trillion, according to Bloomberg News calculations."
"It's closer than you think". And that was in 2017.
---
All of that to say that, despite the best attempts of BlackRock and Vanguard to spin the narrative of "we don't own anything, our investors do" and "we don't own everything", the truth is that BlackRock and Vanguard likely have full autonomy to wield those investor dollars in whatever way they please to, in fact, "own all the biggest corporations in the world".
---
I have also discussed BlackRock, Vanguard, and State Street previously, further evidencing their reach, span of control, and uncanny ability to make money everywhere.
⢠Bloomberg Law tells us that āā¦the likes of BlackRock, State Street, CALPERS, & the Kuwait Investment Authority⦠provide the vast majority of securities used to take bearish positions"
xitter.cf/McSqueezyTheCow/ā¦
⢠BlackRock, through its ownership and influence with Blackstone has been one of many big money organizations buying up swaths of real estate--both residential and commercial--and artificially inflating the housing market and adding to the creation of another bubble
xitter.cf/McSqueezyTheCow/ā¦
⢠Blackstone, which means BlackRock, acquired Ancestry
⢠BlackRock, Vanguard, as well as hedge funds like #Citadel have significant stakes--often with voting rights--in pharmaceutical manufacturers like Sarepta.
It is also worth noting that these asset managers and hedge funds profit handsomely from an FDA process where drugs can be fast-tracked to the market, often without proper trials, testing, and proof of efficacy.
xitter.cf/McSqueezyTheCow/ā¦
Fun Fact: A May 2023 Bloomberg article quoted Diana Zuckerman, President of the National Center for Health Research, a nonprofit think tank:
āSarepta is a poster child for an absolutely outrageous and inexcusable lack of any kind of oversight or enforcementā
So.. Just so you know this is not just Squeezy on a witch hunt against asset managers. BlackRock, Vanguard, and State Street are in cahoots with the likes of a drug manufacturer labeled as a poster child for outrageous and inexcusable lack of oversight and enforcement
---
TLDR: Let's make it all make sense, now...
Eįµ”ponent is a company that creates expertise that creates opportunities for their clients by solving challenges for a safer and healthier world.
#Netflix lets us know that Eįµ”ponent is a "hired gun" of meat, diary, and eggs [lobbyists] that funded research studies that denied evidence connecting food to disease "while burying their involvement in the fine print", and that Eįµ”ponent's "research was used by the tobacco industry to deny the connection between second-hand smoke and cancer"
BlackRock, Vanguard, and State Street have significant stakes in Eįµ”ponent.
BlackRock, Vanguard, and State Street are also involved in the "easy button" trillion dollar pharmaceutical game, the over-inflating the real estate market by buying up blocks of property game, the shorting the economy, by way of lending out large amounts of stock game, and many other things.
---
TLDR²:
Eįµ”ponent's ability to conduct research and provide evidence to push agendas like "mEaT iSnT cOnNeCtEd tO dIsEaSeS, gUys", and countering scientific facts that would promote the overall health of the global population is made possible by big money like BlackRock, Vanguard, and State Street.
Ironically enough, these asset managers who fund research countering science for financial benefit, turn right around and benefit from the quick to market big #pharma marketplace.
These asset managers also buy up huge amounts of property so you cant afford to buy a home, and/or can't find a home to rent.
And if it's not bad enough, these same asset managers buy up millions of shares of stock--off-exchange, as to not allow the stock's price action to reflect the purchases--so they can turn around and lend those shares to short sellers, whose goal is to drive company stock prices into the ground, bankrupting them, and adding to unemployment.. which brings with it implications that can tie right back into them making money from big pharma.
I can go on, but I will digress here.
---
#Food #FDA #BigPharma #Research #Drugs #BlackRock #Vanguard #StateStreet #HedgeFunds #Citadel #RealEstate #StockMarket #ShortAndDistort #TwitterNews
Eįµ”ponent - About:
exponent.com/company-about
Fintel - Exponent, Inc (EXPO) Stock Price, Institutional Holders, and Ownership:
fintel.io/so/us/expo
Fintel - Kayne Anderson Rudnick:
fintel.io/so/us/hhr/kayne-anā¦
CNN Business - Virtus Investment Partners Inc:
money.cnn.com/quote/shareholā¦
December 31, 2022 Schedule 13G:
investors.23andme.com/staticā¦
April 20, 2022 Reuters article:
reuters.com/article/factchecā¦
March 6, 2021 Bloomberg Law article:
news.bloomberglaw.com/securiā¦
December 4, 2020 Blackstone Press Release:
blackstone.com/news/press/blā¦
February 29, 2020 HeadHunter Group PLC Schedule 13G:
sec.gov/Archives/edgar/data/ā¦
December 31, 2020 HeadHunter Group PLC Schedule 13G: sec.gov/Archives/edgar/data/ā¦
November 24, 2020 CNN Business article:
cnn.com/2020/11/24/business/ā¦
February 29, 2020 HeadHunter Group PLC Schedule 13G:
sec.gov/Archives/edgar/data/ā¦
December 4, 2017 Financial Post article:
financialpost.com/investing/ā¦
Investopedia -Voting Rights :
investopedia.com/terms/v/votā¦
(Bloomberg) -- "What started out as a relatively obscure way for drugmakers to get new medicines to patients, accelerated approval is now a business model for some companies"
Now that I have your undivided attention, lets quickly discuss the debacle that is the FDA, and then we'll pivot to more of a 'regularly scheduled programming' topic.
This May 14th Bloomberg article is an eye-opening look into the underbelly of the FDA and their processes, where drugs are fast-tracked to the market, often without trails even started, and often with trails still not started years after the drug is on the market. By that time, drug manufacturers have made billions in profit.
How does this happen?!?
According to the FDA, "In 2012, Congress passed the Food and Drug Administration Safety Innovations Act (FDASIA). Section 901 of FDASIA amends the Federal Food, Drug, and Cosmetic Act (FD&C Act) to allow the FDA to base accelerated approval for drugs for serious conditions that fill an unmet medical need on whether the drug has an effect on a surrogate or an intermediate clinical endpoint".
FDA goes on to note that "A surrogate endpoint--an indicator or sign used in place of another to tell if a treatment works while in clinical trials--used for accelerated approval is a marker - a laboratory, measurement, radiographic image, physical sign or other measure that is thought to predict clinical benefit, but is not itself a measure of clinical benefit"
In other words, an indicator or sign used to show a treatment works for clinical trials--and likely a key requirement of accelerated approval--can be a laboratory, measurement, or image, but doesn't have to be a measurable clinical benefit (i.e., trial results).
...Convenient!
More colorful commentary from the article:
"A Bloomberg News analysis of Food and Drug Administration databases found 19 drugs with accelerated approvals whose confirmatory trials are still listed as delayed as of April. That includes studies that are past their official due dates as well as trials running behind schedule"
"Critics argue the FDA hasnāt done enough to force companies to produce conclusive data on drugs theyāre already selling"
"Meanwhile, people are taking drugs every day that havenāt met the FDAās typical standard for approval"
"Amid growing controversy over the approval pathway, the agency [FDA] is trying harder to get these drugs off the market when the required confirmatory trials arenāt completed or fail to prove drugs work"
"Over the past three decades, around 300 applications have used the accelerated process, mostly for cancer medicines. In some years, more than 20% of all new drugs that hit the market came from this pathway"
"People could be spending the last year of their lives taking something that ultimately turns out to be a dud"
Is it all bad?
Likely, No. The article does make mention of Exondys--which we mentioned earlier, whose success has allowed, "the company [Sarepta] to raise billions of dollars that it has plowed back into gene therapy research and manufacturing that could help far more patients".
But as we know, in some cases, if you give someone an inch, they'll take a mile.
The same article also quotes Diana Zuckerman, president of the National Center for Health Research, a nonprofit think tank:
āSarepta is a poster child for an absolutely outrageous and inexcusable lack of any kind of oversight or enforcementā
So..."Where are you going with this?", I'm sure many are wondering. This topic is a far cry from my usual posts.
Enter hedge funds and asset managers...a/k/a 'regularly scheduled programming'
⢠Asset Managers
Looking at Sarepta's stock, we see that Vanguard and BlackRock own 9.15 and 6.30 percent stakes in the company; enough for a handsome profit, I'm sure.
Other drugs/makers mentioned in the article...
In the case of Novartis, the maker of Gleevec, BlackRock owns 5.4 percent.
In the case of Merck & Co, the maker of Keytruda, Vanguard and BlackRock own 8.96 and 8.50 percent, respectively.
In the case of Bristol Meyers Squibb, the maker of Opdivo, Vanguard and BlackRock own 9.54 and 8.10 percent, respectively.
⢠Hedge Funds. You know where this is going..
A simple screenshot on recent 13G filings of Citadel shows a lot of activity. For example, looking into MoonLake Immunotherapeutics's 13G, we see that between Citadel Advisors LLC, Citadel Advisors Holdings LP and Citadel GP LLC, each entity owns 7.4%; or 2,873,311 shares, as of the December 31, 2022 filing.
And of yea, Ken Griffin owns another 7.4%, or 2,886,092 shares, bringing Citadel's total ownership
Citadel Securities LLC, Citadel Securities Group LP, and Citadel Securities GP LLC round out the group with 12,781 shares each.
According to Fintel, only Citadel Advisors Llc remains as a shareholder, with 2,923,438 shares.
I would expect all those shares made Citadel a nice profit. A little 'rinse and repeat' across however many bio-therapeautic-pharmaceuticals companies there are, and it's easy to see how this can add up, and quick!
So, Who is MoonLake Immunotherapeutics?
According to their website, Moonlake is "a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational NanobodyĀ® for the treatment of inflammation, to revolutionize outcomes for patients".
Sonelokimab treats inflammatroy diseases.
On May 3rd of this year, Moonlake announced a partnership with Siemens Healthineers "to develop an autoinjector for clinical and potential subsequent commercial supply of MoonLakeās Nanobody sonelokimab" utilizing SHL's Molly modular platform. SHL's Molly modular platform is used across 17 products in 69 different countries.
So, yea... big business for anyone invested in [accelerated] drug sales.
TLDR: The FDA has established a system in which [potentially life saving] drugs can be fast-tracked to the market, without proper trials, testing, and proof of efficacy. This "easy button" approach to medicine results in profit for financial backers, companies, and shareholders, but for those taking drugs that can be "duds", may lead to continued sickness, worse conditions that before taking a new drug, or in a worse-case scenario, death.
Why?!?!
Because money over everything [Likely]. Another case of big money--and in this case big pharma, as well--putting profits before patients, patrons, etc. The likes of Vanguard, BlackRock, Citadel, and other familiar names are likely making hand over fist in the process.
#FDA #BigPharma #Drugs #BlackRock #Vanguard #HedgeFunds #Citadel #TwitterNews
May 14, 2023 Bloomberg article:
bnnbloomberg.ca/drug-companiā¦
FDA - Accelerated Approval article:
fda.gov/patients/fast-track-ā¦
National Cancer Institute - Surrogate Endpoint:
cancer.gov/publications/dictā¦
Sarepta Therapeutics (SRPT) Institutional Ownership:
fintel.io/so/us/srpt
Novartis (NVS) Institutional Ownership:
fintel.io/so/us/nvs
Bristol Meyers Squibb (BMY) Institutional Ownership:
fintel.io/so/us/bmy
December 31, 2022 MoonLake Immunotherapeutics Schedule 13G:
sec.gov/Archives/edgar/data/ā¦
MoonLake Immunotherapeutics (MLTX) Institutional Ownership:
fintel.io/so/us/mltx
Moonlake - About Us
moonlaketx.com/about-us/
May 3, 2023 Press Release - MoonLake Immunotherapeutics and SHL Medical collaborate to jointly develop an autoinjector for sonelokimab supply:
globenewswire.com/news-releaā¦
Yeggles retweeted
To sum it up, the creation of APEs should help clarify for you who is in our current shareholder base and how many company issued shares there are. Beyond that, though, we believe APES should let AMC raise capital, pay debt and do more. Not good news for the doubters. #Checkmate
Yeggles retweeted
$AMC šØ8.28.2023 part 2šØ- PREMARKET - SHITADEL INSECURITIES manipulation.
Look at the ALGORITHMS naked short selling on every uptick and spoof flicking the price down.
Market maker crimes⦠#AMC #MarketMakingFraud #KenGriffinLiedUnderOath #Shitadelinsecurities #KenGriffinIdBernieMadoff
$AMC Premarket 8.28.2023 - Market Makers doing blatant algorithm naked short-sale spoofing on every uptick.
This criminal activity to prevent a volatile rise in price. #CitadelScandal #KenGriffinLiedUnderOath #KenGriffinIsBernieMadoff
Yeggles retweeted
NSCC has proposed further modifications to the Rule book, most of which redacted from public view.
Changes we can see all pertain to Rule 18, Procedures for when the Corporation (NSCC) ceases to act for a defaulting member.






































